What NKure Therapeutics does
Founded in 2021, NKure Therapeutics operates in Health Tech industry. Initially, the company focused on developing advanced therapies for unmet medical needs targeting oncology and rare genetic disorders. NKure Therapeutics launched proprietary technology aimed at enhancing the safety and efficacy of its therapies. The company has expanded its offerings by incorporating advanced delivery platforms for its genetic therapies. Competing with companies such as Eyestem and 4baseCare.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about NKure Therapeutics yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.